To further confirm the potential of our reconstruction method for the detection of expanding cell clones harboring multiple IS in a polyclonal setting, we took advantage of a preclinical model of HSC gene therapy (GT) based on tumor-prone Cdkn2a-/- Lineage- (Lin-) cells. The gene discussed is CDKN2A; the disease is neoplasm.